Enterprise Bank & Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Enterprise Bank & Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-23,124	Closed	-$2.08M	–	98
2022 Q1	$2.08M	Sell	23,124 -1,599	-6%	-$148K	0.82%	42
2021 Q4	$2.77M	Buy	24,723 +279	+1%	+$33.6K	0.97%	38
2021 Q3	$3.07M	Sell	24,444 -116	-0.5%	-$14.9K	1.21%	30
2021 Q2	$3.33M	Buy	24,560 +401	+2%	+$52.7K	1.31%	23
2021 Q1	$3.28M	Buy	24,159 +120	+0.5%	+$18K	1.38%	20
2020 Q4	$3.38M	Buy	24,039 +1,769	+8%	+$227K	1.45%	18
2020 Q3	$2.48M	Sell	22,270 -575	-3%	-$64.5K	1.17%	28
2020 Q2	$2.56M	Buy	22,845 +287	+1%	+$28.3K	1.28%	26
2020 Q1	$1.75M	Sell	22,558 -566	-2%	-$50.1K	1.03%	31
2019 Q4	$2.2M	Buy	23,124 +916	+4%	+$79.2K	0.99%	34
2019 Q3	$1.69M	Buy	22,208 +5,030	+29%	+$418K	0.82%	41
2019 Q2	$1.51M	Buy	17,178 +1,869	+12%	+$159K	0.78%	45
2019 Q1	$1.39M	Buy	+15,309	New	+$1.3M	0.57%	53

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Enterprise Bank & Trust's XBI Position: Q2 2022 in Review

Enterprise Bank & Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 23,124 shares — an estimated $2.08M sold.

Enterprise Bank & Trust first reported a position in XBI in Q1 2019 and held it in 13 quarters. The position peaked at $3.38M in Q4 2020. 704 funds tracked by Wall St. Rank hold XBI as of Q2 2022.

Enterprise Bank & Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
Enterprise Bank & Trust sold 23,124 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $2.08M.
Enterprise Bank & Trust first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 13 quarters.
Enterprise Bank & Trust's State Street SPDR S&P Biotech ETF position peaked at $3.38M in Q4 2020.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.

Based on Enterprise Bank & Trust's 13F filing for Q2 2022, filed 6 Jul 2022.